Cttq
Quick facts
Marketed products
- Generic Zoledronic Acid · Oncology, Bone Metabolism
Zoledronic acid inhibits osteoclast-mediated bone resorption by blocking farnesyl pyrophosphate synthase in the mevalonate pathway. - Original Zoledronic Acid
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: